Ligand-binding epitopes of proteins can mutate rapidly, as shown by viral mutations that lead to escape from neutralizing antibodies. We have undertaken to recreate in vitro the evolutionary competition between viral mutations that allow escape from antibody binding and host mutations that generate new neutralizing antibodies to the mutated viral antigen. To examine this vital race, we describe a phage-based method that allows rapid analysis of molecules that perturb the binding of proteins to their ligands. Because the system can amplify by replication, single-molecule sensitivity can be achieved. When combinatorial protein or smallmolecule libraries are studied, large numbers of binding events can be analyzed simultaneously. Such libraries may be used in a sequential phage escape format, where cycles of phage binding and release of mutants are driven by antibodies or small molecules and the difficulty of escape increases at each cycle. Ultimately, the sequencing of the viral mutants allows annotation of the allowed trajectory of escape. Likewise, sequencing of the antibody perturbants charts the chemistry of the immune system response to the viral challenge. We have termed such analysis of competing mutations a ''checkmate analysis.'' When viral systems are studied, a checkmate analysis allows experimental evaluation of the evolutionary contest between viruses and the immune system and may predict which antibodies and small-molecule ligands should be generated in anticipation of viral mutations before these mutations create viral epidemics.
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high-throughput screening ͉ influenza ͉ single-molecule detection ͉ small-molecule inhibitors ͉ combinatorial antibody libraries I n a process that Burton (1) called the ''clash of evolutionary titans,'' new viruses and neutralizing antibodies are sequentially selected by the pressure they exert on each other during infections. In this process, the immune system necessarily operates in a reactive mode and cannot be proactive. In practice, new vaccines or passive antibodies are designed against what the virus has done rather than what the virus might do. From a structural point of view, the contest is usually played out between the relatively unstructured protein loops of both systems, where generation of the 3D structural diversity of these portions of the protein does not impact the overall protein function. Hence, the allowed diversity space of both systems is large, thereby making an analysis of where the virus can mutate in terms of the primary sequence space and how antibodies subsequently respond to an extremely difficult problem.
The advent of combinatorial antibody libraries and phage display technology has allowed experimental access to collections of antibodies with diversity exceeding that of the native immune system from which they are derived (2) , and thus such antibody collections can contain neutralization solutions to any sequence space accessible to the virus. The central requirement for an analysis of how the virus evades antibody neutralization involves the time-honored experimental process of generating a set of annotated escape mutants. However, as currently practiced, the process involves cycles of infection and neutralization in tissue culture, which is inherently slow and does not lend itself to the generation of large databases.
We can envisage a methodology termed a ''checkmate analysis,'' which can quickly explore the possible routes that a virus can take to escape an immune response or therapeutic small molecule. In an immunological checkmate analysis, one starts with large libraries of mutant viral proteins and antibodies that are expressed on the surface of the phage encoding them and can be used to challenge each other. Successful members of each collection can be easily replicated and analyzed as a consequence of the inherent phenotype-genotype link engendered by phage display, thus allowing a detailed chemical map of the trajectories of viral escape and antibody response.
The two requirements for a checkmate analysis are (i) the expression in phage of a functional viral protein neutralization target and (ii) an antibody or small-molecule library that binds to epitopes on this target. The methods for generation of combinatorial small-molecule or antibody libraries (3) (4) (5) (6) are well established. Many libraries are currently available or easily constructed. However, the expression of functional viral proteins on phage is not as obvious, because these proteins are often assembled in a membrane and can be multimeric, as in the case of the trimeric influenza viral HA (7). We have successfully designed a system to express a functional influenza virus HA system on the phage surface. The feasibility of using this system for a checkmate analysis was demonstrated by phage-mediated agglutination of RBCs and inhibition with appropriate ligands. In this way, we provide the missing component for a predictive checkmate analysis, allowing us to isolate escape variants or, in an alternative format, to identify ligands that antagonize a given interaction.
Results and Discussion
Ultimately, in this article we describe two concepts: phage escape libraries and checkmate analysis. When reduced to their essences, phage escape libraries are the experimental centerpiece of the technology, whereas the binary protocol of a checkmate analysis is a powerful algorithm for generating the most useful information from such libraries. There are many protocols that one might use for an immunological checkmate analysis of the influenza virus system. The simplest might start with a single HA strain and a modestly sized collection of antibodies that neutralize this strain of virus. Because the sequences of the antibodies are known, the diversity of the starting library can be expanded while preserving the amino acids that a consensus analysis suggests are critical for binding the viral epitope. There are many ways to generate diversity in phage libraries, including point mutations and heavy-and light-chain or complementarity determining region (CDR) shuffling (8) . In combination, the procedures allow the generation of virtually unlimited diversity that goes far beyond anything that the virus might encounter in an in vivo setting, where responsive antibody diversity is limited to somatic mutation of a rather limited starting population of neutralizing antibodies. A sample protocol ( Fig. 1 ) might involve a starting population of HA-containing phage that binds to a solid support (termed phage ''down'') and an antibody or small-molecule collection that prevents attachment (termed phage ''up''). The HA is then mutated, and the escape variants (phage down), which still preserve binding capacity, are selected. These variants can be used to screen for new variants of the antagonists that can capture the escape mutants. At each iteration, the viral and antibody variants are deconvoluted and annotated. The challenge to the virus escalates as the collection of new antibodies and small-molecule antagonists grows and is added to each cycle. In the case of an immunological checkmate analysis, the sequence analysis of successful viral mutants provides a map of escape routes the virus can use, and, similarly, the sequences of the antibodies give information about the chemical basis of a successful immune response. For this process to succeed, a functional viral protein must be robustly displayed as a fusion protein with a phage coat protein.
To assemble HA as a functional trimer on the surface of M13 bacteriophage, the coexpression of soluble HA monomers, as well as an HA monomer, attached to a phage coat protein is required. An elegant solution to this problem can be achieved by employing a suppressible amber codon in the linker between phage coat protein and HA, thereby allowing conditional fusion of a single HA monomer to the phage coat and simultaneous expression of the requisite soluble monomers (9) . Fortunately, the most widely used phagemid vectors have been constructed in such a fashion that the inserted gene is located 5Ј to the pIII coat protein with an amber suppressor codon between the two proteins ( Fig. 2A) to allow for rapid conversion from a selection vector to an expression vector (3, 6) . This vector design perfectly fulfills our requirements for a checkmate analysis. However, to prevent unintended membrane association of soluble HA monomers, the relative hydrophobic pelB signal sequence from phagemid pCGMT was replaced with the more hydrophilic dgal signal sequence (MNKKVLTLSAVMASMLFGAAAHA). Using this phagemid system and the judicious choice of host strains with appropriate suppressor activity, we anticipated that HA monomers would be expressed and efficiently routed to the periplasmic space. Given the extremely small volume of this space (Ͻ1.0 ϫ 10 Ϫ15 liters), only a few hundred molecules will be present at micromolar concentrations and thus thermodynamically drive the assembly of trimeric HA.
EM of the resulting phage-HA clones revealed the presence of specific immunogold labeling at only one end of the phage, consistent with pIII display (Fig. 2B) . Furthermore, Western blot analysis of pIII-HA fusion proteins further confirmed the successful expression of HA monomers on the phage surface (Fig. 2C) . Interestingly, this analysis also indicated the successful assembly of dimeric and trimeric HA, albeit without confirming that this protein was folded into a functional trimeric conformation. Next, addition of a collection of known neutralizing antibodies yields the phage up state, after which mutagenesis of the phage-HA clones and selection for binding to RBCs yield an HA library composed of the original clones as well as mutant HA molecules that retain the ability to bind RBCs (red phage). Subsequent addition of neutralizing antibodies isolates the phage down escape mutant. Standard panning procedures using combinatorial antibody libraries can then identify specific antibodies that can neutralize this escape variant (red antibody), which is then added to the pool of antagonists, resulting in all phage possessing the phage up phenotype (top of the cycle). This cycle can then be iterated with an increasingly larger pool of neutralizing antibodies, thus raising the barrier necessary for escape at each cycle.
In addition to the confirmation of pIII-HA fusion protein expression, a checkmate analysis inherently requires the production of a functionally folded protein, and we therefore examined the ability of these constructs to agglutinate RBCs. In the influenza virus, the affinity of a single HA trimer to bind its cognate sialic acid ligand on the RBC surface is weak (K d Ϸ 1 mM) (10) . However, given the large number of HA molecules on the viral surface, a significant decrease in the observed binding constant can be achieved because of multivalent binding interactions with multiple sialic acid moieties. To retain infectivity for further amplification, each phage can possess only a limited number of HA trimers (usually one). Thus, to achieve efficient agglutination, adjacent phage molecules must be cross-linked on the RBC surface to mimic the native interaction. By using antibodies against either the major phage coat protein VIII or the conserved region of HA, a multivalent system can be generated that cross-links both sialic acid residues on the same cell as well as adjacent RBCs (11) . By using this strategy, agglutination of both human and avian RBCs was readily observed only in phage-HA clones and not wild-type phage (Fig.  3) . In contrast to previous reports that necessitated the inclusion of a ''foldon'' sequence to facilitate trimerization in a baculovirus expression system (12), modified HA-foldon constructs were no more efficient at agglutination in our Escherichia coli expression system than those without the foldon sequence. Presumably, this discrepancy is a consequence of the thermodynamically driven assembly of trimeric HA in the small volume of the periplasmic space, compared with the larger volume of a mammalian or insect cell. Although we use antibodies in this case to amplify the signal, we do not expect this requirement to generally apply to an analysis of viral escape routes, through which direct binding to an immobilized ligand is studied. These antibodies are required for the special case of RBC agglutination by HA because individual HA trimers are incapable of cross-linking adjacent cells. By contrast, influenza viral particles are capable of hemagglutination as a result of the high copy number of HA trimers on the virion surface.
An additional validation of our vector design strategy for simultaneous expression of soluble HA and fusion protein was performed by mutating the amber suppressor codon to encode for a glutamine residue, resulting in the expression of only monomeric HA as a pIII fusion, such that a given phage will possess, on average, only a single HA monomer. Indeed, phages produced from this modified construct did not agglutinate RBCs (Fig. 3) . The different agglutination behavior of phage produced from these different vectors provides strong evidence for the formation of functional trimeric HA when the amber suppressor codon is used. Further examination of nonagglutinated and agglutinated RBCs at the microscopic level showed specific punctate staining of the RBC membrane by phage-containing trimeric HA (Fig. 4A) and, in particular, localization of phage to the interface between neighboring agglutinated RBCs (Fig. 4 B-D) .
With a system for expression of functional phage-HA in hand, we next turned our attention to the ability of appropriate ligands to antagonize HA function and prevent agglutination. Extensive characterization by others of the preferences of HA proteins to bind to sialic acid-containing oligosaccharides has been carried out (11) . On the basis of these analyses, a series of oligosaccharides were chosen as suitable ligands for the prevention of phage-HA-induced agglutination. Indeed, each of these oligosaccharides could inhibit agglutination (Fig. 5 ). This finding is particularly crucial for a successful checkmate analysis because the functional assay used to annotate the proteins that escape the antibodies or small molecules must provide a reliable readout of the relative ability of a given molecule to perturb the biological interaction. To put this idea another way, the assay used to assess potential escape (in this case, HA clones that continue to agglutinate RBCs in the presence of a given antagonist) must recapitulate the biophysical characteristics of the native system in achieving oligomerization.
There are at least two obviously useful outcomes of a checkmate analysis. The first is simply the construction of a prospective map of allowed routes by which the virus can escape antibody neutralization or small-molecule antagonism. These routes can be correlated with outcomes of actual viral infections and computational analysis. Thus, we have termed libraries of these viral proteins ''phage escape libraries'' because they should ultimately contain all of the solutions the virus can use to escape immunological or pharmacological interventions. The second, but less certain, outcome pertains to whether one can actually generate a collection of molecules that anticipate the most likely or most favorable routes of virus escape. Such antibody or small-molecule collections could be stored and might find use because they would be quickly available to help stop the spread of a newly emerging highly pathogenic virus, such as avian inf luenza, which has escaped surveillance. An important practical outcome of immunological checkmate analyses is that one could build amalgamated antibodies that contain consensus sequences that were selected on the basis of response to several cycles of virus escape. The success of an antibody collective in anticipating the routes of virus escape depends on the diversity that is allowed in the protein loops that are the targets of virus neutralization. If there is total degeneracy in the viral protein loops, the problem is difficult. However, one expects that there will be structural constraints on viral proteins, and the allowed diversity may be somewhat limited, even for protein loops.
Although not strictly related to a checkmate analysis, the harvesting of such a large number of antibodies might yield rare species that broadly neutralize because they are directed to the invariant regions of viral proteins. Because of their rarity, such antibodies may have been missed when a limited number of hybridomas or the bulk antibody response is analyzed. Such antibodies have recently been observed when combinatorial antibody libraries against HIV (13) or hepatitis C have been studied (M. A. A. Persson, personal communication). In terms of the present case, one should realize that because a target is present in a replicating particle, phage escape technology can operate at the single-molecule level. In addition, the approach can be readily implemented in other display systems, such as yeast (14), which might allow expression of more complicated receptors, such as G protein-coupled receptors.
Finally, we note that checkmate analyses are not limited to viral systems but can be applied to any perturbable protein-ligand interaction. When iterative cycles of binding and escape are studied, phage escape libraries and checkmate analysis provide information about critical regions in proteins. For instance, when enzyme inhibitors are examined, analysis of the cycles can essentially map the active site. Alternatively, regions of allosteric control or higherorder protein-protein interactions can be located. For example, analysis of escape mutants could be useful in defining active site topology and/or profiling escape trajectories of enzymes important to cancer phenotypes (15) or protein changes leading to antibiotic resistance in bacteria. One also can envisage using this methodology in high-throughput screening procedures for which organic compounds or small peptides, rather than antibodies, are used to disrupt the interaction between protein and ligand. In this scenario, one can find specific antagonists of a given protein-ligand simply by measuring bacterial growth where drug resistance is conferred by infection with phages that escaped. In essence, because the readout of this system is replication, it allows analysis of direct binding at the level of single molecules without the requirement of special reagents or complicated equipment for implementation.
Methods
Vector Construction. The dgal signal sequence was ligated into the pCGMT phagemid between EcoRI and HindIII restriction sites, which in turn also removed the pelB signal sequence. Influenza HA [residues 11-329 (HA1) and 1-176 (HA2) of the ectodomain of HA from A/Vietnam/1203/2004] was amplified by PCR and ligated into dgal-pCGMT between a 5Ј XmaI restriction site and 3Ј SfiI restriction site to generate the desired dgal-HA insert into pCGMT.
To modify the amber suppressor within the dgal-HA-pCGMT vector to encode for a glutamine residue, site-directed mutagenesis was accomplished by using a QuikChange mutagenesis kit (Stratagene, La Jolla, CA).
Incorporation of a foldon sequence 5Ј to the HA gene was accomplished by ligation of the desired sequence into the dgal-pCGMT phagemid between the SfiI and SpeI restriction sites. Subsequently, the HA gene was incorporated between the XmaI and XhoI restriction sites to yield the desired dgal-foldon-HA-pCGMT phagemid.
Phage-HA Expression. Wild-type and HA (30 g/liter peptone, 20 g/liter yeast extract, 10 g/liter Mops) phagemid-harboring cells were cultured overnight in super broth medium containing 10 g/ml tetracycline or 50 g/ml carbenicillin and 10 g/ml tetracycline, respectively. Fresh super broth medium with 2% fructose and appropriate antibiotics was inoculated with 1% overnight culture and grown at 37°C to an OD 600 of 0.5-0.7, after which 1.0 ϫ 10 11 to 3.0 ϫ 10 11 pfu/ml VCSM13 helper phage was added, and cultures were rocked gently at 37°C for 30 min and then shaken at 37°C for 1 h. Kanamycin was added to a final concentration of 70 g/ml, and cultures were grown overnight at 28°C. Cultures were centrifuged at 12,000 ϫ g for 20 min to pellet cells, and phage was precipitated from the supernatant by adding NaCl and PEG 8000 to final concentrations of 3% and 4%, respectively, and then incubated on ice for 30 min. Phage was removed from the solution by centrifuging samples at 12,000 ϫ g for 20 min and resuspending the phage pellet in 2-3 ml of PBS. Any residual E. coli was removed by centrifuging the resuspended phage samples at 16,000 ϫ g for 10 min. Phage samples were stored for up to 2 weeks at 4°C.
EM. All aqueous solutions were prepared with distilled, deionized water (Mediatech, Herndon, VA), and each step was carried out by transferring each grid through individual droplets on Parafilm. Pioloform-coated 400-mesh, nickel grids were first rinsed in 0.05% aqueous Bacitracin (Sigma-Aldrich, St. Louis, MO) and then, while still wet, incubated for 10 min on droplets of either wild-type or HA-expressing phage both diluted 1:20 in water. The samples were blocked in 2% BSA in TBS [25 mM Tris base/137 mM NaCl (pH 8.2)] for 20 min, followed by 2 min in murine anti-HA monoclonal antibody 12CA5 (9.3 mg/ml) diluted 1:50 in 0.5% BSA in TBS. The grids were washed six times in 0.2% BSA in TBS for 1 min, incubated in goat anti-mouse polyclonal antibody tagged with 6-nm gold at 1:100 for 5 min (Jackson ImmunoResearch Laboratories, West Grove, PA), and washed six times in TBS for 1 min and then once in water for 1 min. To stabilize the samples, the grids were f loated on 0.2% aqueous glutaraldehyde for 5 min, washed four times in water for 1 min and then twice in 0.1% aqueous ammonium acetate for 1 min, and finally negatively stained in 2% aqueous uranyl acetate for 2 min. Excess liquid was removed, and the grids were allowed to dry before being examined on a Philips CM100 electron microscope (FEI, Hillsborough, OR). Images were documented with Kodak SO163 EM film (Eastman Kodak, Rochester, NY). Negatives were scanned at 600 lines per inch with a Fuji FineScan 2750xl and converted to .tif format for subsequent handling in Adobe PhotoShop (Adobe Systems, Mountain View, CA).
RBC Agglutination. Chicken erythrocytes were separated from whole blood in heparin (Rockland, Gilbertsville, PA) with the Accuspin System Histopaque 1077 (Sigma-Aldrich). After isolation and washing, 25 l of chicken or human RBCs were added to 975 l of PBS, and this cell suspension was used to make 1:1 serial dilutions in PBS in a V-bottom 96-well plate (total volume, 50 l). The plate was centrifuged at 1,000 ϫ g for 5 min, and the supernatant was discarded. Aliquots of dgal-HA phage or PBS (50 l) were added to each well, and the plate was incubated at 37°C with shaking for 1 h, after which the plate was centrifuged at 1,000 ϫ g for 5 min and the supernatant was discarded. The plate was then washed two times by adding 50 l of PBS, resuspending the cells, centrifuging at 1,000 ϫ g for 5 min, and discarding the supernatant. A 50-l aliquot of mouse anti-HA 12CA5 antibody was added to each well, and the plate was incubated at 37°C with shaking for 1 h. The plate was centrifuged at 1,000 ϫ g for 5 min, and the supernatant was discarded. The plate was then washed two times by adding 50 l of PBS, resuspending the cells, centrifuging at 1,000 ϫ g for 5 min, and discarding the supernatant. Finally, a 50-l aliquot of a 1:1,000 dilution of goat anti-mouse polyvalent Ig (Sigma-Aldrich) was added to each well, and the plate was incubated at 37°C with shaking overnight. Subsequently, the plate was centrifuged at 1,000 ϫ g for 5 min and visually checked for RBC agglutination.
Agglutination inhibition experiments were performed by using ␣-acid glycoprotein (Sigma-Aldrich), Neu5Ac␣2,3Gal␤1, 3GlcNAc␤-Sp (3ЈSLe c ), or NeuAc␣2,3Gal␤1,4GlcNeuAc␤-Sp (3Ј-SLN). Experiments were performed as described earlier, except that before addition to RBCs, phage-displayed HA was preincubated for 5 min at room temperature with appropriate competing ligand.
Fluorescence Confocal Microscopy. Chicken RBCs were agglutinated with 20 g/ml wheat germ agglutinin (Invitrogen, Carlsbad, CA) for 1 h at 37°C with constant agitation. Wheat germ agglutinin-agglutinated cells were then treated with HA-phage as described. Doubly agglutinated cells were then fixed and labeled for microscopy. Cells were washed twice in 10 volumes of endotoxin-free PBS (Cambrex, East Rutherford, NJ), fixed in 2% EM-grade paraformaldehyde (Sigma-Aldrich) for 20 min, washed twice in 5 volumes of PBS, and permeabilized in 0.1% Triton X-100 for 2 min. Cells were washed as before, blocked in 10% normal goat serum for 30 min, washed again, and incubated in 5 g/ml anti-M13 monoclonal antibody (GE Healthcare, Chalfont St. Giles, U.K.) for 1 h. Cells were washed again and incubated in 5 g/ml goat anti-mouse Alexa Fluor 488 (Invitrogen) for 1 h. Cells were rinsed twice as before and incubated in 5 l of Vybrant DiI (Invitrogen) per milliliter of cell suspension for 30 min. Cells were rinsed twice as before and incubated in 5 M TOTO-3-iodide (Invitrogen) for 30 min. Poly-D-lysine coverslips were prepared by incubating coverslips in 50 g/ml poly-D-lysine (Sigma-Aldrich) for 1 h at 37°C and allowing them to air dry. Cells were rinsed twice and attached to poly-D-lysinecoated coverslips via centrifugation. Coverslips were mounted onto slides with the Slowfade Anti-fade kit (Invitrogen) and imaged on a Bio-Rad (Hercules, CA) MRC1024 laser scanning confocal microscope.
